The stock's rise snapped a three-day losing streak.

Shares of Bio-Techne Corp. TECH shed 2.18% to $57.35 Tuesday, on what proved to be an all-around mixed trading session for ...

Bio-Techne (TECH) announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics, or ACD, ...

Shareholders of Bio-Techne would probably like to forget the past six months even happened. The stock has dropped 26.9% and ...

Bio-Techne Corporation TECH recently opened a new Customer Experience Centre in Düsseldorf, Germany, to serve customers across the Europe, Middle East and Africa (“EMEA”) region. The facility's ...

Learn more about whether Repligen Corporation or Bio-Techne Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Corporation announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...

Dr. Gregory Bean, Associate Professor of Pathology at Stanford University, will describe the direct detection of mRNA from CRTC1/3::MAML2 translocations, as alternatives to MAML2 FISH, in the ...

Equities research analysts at Evercore ISI assumed coverage on shares of Bio-Techne (NASDAQ:TECH – Get Free Report) in a report released on Tuesday, Ratings reports. The firm set an “outperform” ...

Bio-Techne Corporation TECH recently opened a new Customer Experience Centre in Düsseldorf, Germany, to serve customers across the Europe, Middle East and Africa (“EMEA”) region. The facility ...